4:21 PM
 | 
Dec 30, 2011
 |  BC Extra  |  Top Story

Expanded label for Prevnar 13

FDA granted accelerated approval to Prevnar 13 from Pfizer Inc. (NYSE:PFE) to prevent pneumococcal disease in adults 50 years and older. FDA approved the product based in part on...

Read the full 133 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >